[Differences in the MLV and HIV-1 integration sites could be important for gene therapy].
Jeanteur
Philippe
P
D002648:Child; D015316:Genetic Therapy / Q000009:adverse effects; D015497:HIV-1 / Q000502:physiology*; D006801:Humans; D007938:Leukemia / Q000235:genetics / Q000821:virology; D009052:Leukemia Virus, Murine / Q000502:physiology*; D016511:Severe Combined Immunodeficiency / Q000628:therapy; D016662:Virus Integration / Q000502:physiology*